Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • SylvainL
    Senior Member
    • Feb 2012
    • 180

    #1

    Two-way repeated-measures ANOVA?

    Dear all,

    A researcher came with this design of data and asked me which statistical test will be the most appropriate to see if the difference after treat ment between cells1 and cells2 is significant...

    Code:
    >mydata
        Cell Experiment Treatment Value
    1  Cell1          1 untreated  4.41
    2  Cell1          1   treated 17.60
    3  Cell1          2 untreated  4.10
    4  Cell1          2   treated 11.50
    5  Cell1          3 untreated  5.21
    6  Cell1          3   treated  7.84
    7  Cell2          1 untreated  4.67
    8  Cell2          1   treated  5.55
    9  Cell2          2 untreated  4.23
    10 Cell2          2   treated  5.41
    11 Cell2          3 untreated  5.61
    12 Cell2          3   treated  7.69
    I have now to mention that I am not a statistician. After having a look, it seems that Two-way repeated-measures ANOVA would be the most appropriate test. Is it correct?

    I set the model like this: Value ~ Cell * Treatment + Error(Experiment/Treatment)

    and called
    Code:
    aov.out <- aov(Value ~ Cell * Treatment + Error(Experiment/Treatment), data=mydata)
    
    > summary(aov.out)
    
    Error: Experiment
              Df Sum Sq Mean Sq F value Pr(>F)
    Residuals  2  7.056   3.528               
    
    Error: Experiment:Treatment
              Df Sum Sq Mean Sq F value Pr(>F)  
    Treatment  1  62.38   62.38   11.28 0.0784 .
    Residuals  2  11.06    5.53                 
    ---
    Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
    
    Error: Within
                   Df Sum Sq Mean Sq F value Pr(>F)
    Cell            1  25.52  25.521   2.882  0.165
    Cell:Treatment  1  30.34  30.337   3.426  0.138
    Residuals       4  35.42   8.855

    But I am absolutely not sure about my model and I do not understand the output...

    Thanks in adavance,

    s.
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    I personally wouldn't use a random effect for something like this, there aren't enough samples taken in each group for it to be of much use (IMHO, though I'm sure there's a paper with suggestions regarding this). I'd just:

    Code:
    summary(aov(Value~Experiment+Treatment*Cell, df))
    Note that there's nothing that you can reasonably do to make the interaction p-value < 0.05, there's too much variance in cell1.

    Comment

    • SylvainL
      Senior Member
      • Feb 2012
      • 180

      #3
      Hi,

      So, to be sure, since what I want to see it whether the treatment as a different effect on the cell type, the pvalue I am insterested by is the Treatment:Cell. Is it correct?

      Code:
      > summary(aov(Value~Experiment+Treatment*Cell, mydata))
                     Df Sum Sq Mean Sq F value Pr(>F)  
      Experiment      2   8.13    4.07   0.515 0.6261  
      Treatment       1  62.84   62.84   7.958 0.0371 *
      Cell            1  23.58   23.58   2.986 0.1446  
      Treatment:Cell  1  37.20   37.20   4.711 0.0821 .
      Residuals       5  39.48    7.90                 
      ---
      Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
      Which in this case is not

      s.

      Comment

      • dpryan
        Devon Ryan
        • Jul 2011
        • 3478

        #4
        Correct. It's trending toward significance and might well get there, but more samples would be needed.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 11:13 AM
        0 responses
        19 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, Yesterday, 10:48 AM
        0 responses
        18 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        42 views
        0 reactions
        Last Post SEQadmin2  
        Working...